Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Virginie Louvain-Quintard"'
Autor:
Audrey Imbert, Sylvie Doubine, Youssef Zarrouki, Virginie Trehel-Tursis, Virginie Louvain-Quintard, François Stéphan
Publikováno v:
Chest. 142:837-844
The diagnosis of heparin-induced thrombocytopenia (HIT) is problematic in the surgical ICU, as there are multiple potential explanations for thrombocytopenia. We conducted a study to assess the incidence, clinical presentation, and outcome of HIT in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d591fead3313b4c54a0324ce51b70f18
https://doi.org/10.1378/chest.11-3074
https://doi.org/10.1378/chest.11-3074
Autor:
Saida Rezaiguia-Delclaux, François Stéphan, Florent Laverdure, Virginie Louvain-Quintard, Audrey Imbert, Talna Kortchinsky
Publikováno v:
Intensive Care Medicine. 42:1082-1083
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53850da8da8297e41fac3513f13a1bc1
https://doi.org/10.1007/s00134-016-4262-2
https://doi.org/10.1007/s00134-016-4262-2
Autor:
Roland Couturier, Vregina Anerkian, Marina Rubatti, Stanislas Grassin-Delyle, Marc Vasse, Carmen Credico, Sylvie Doubine, Virginie Louvain-Quintard
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 25(3)
Tranexamic acid is given continuously or discontinuously as an anti-fibrinolytic therapy during cardiac surgery, but the effects on fibrinolysis parameters remain poorly investigated. We sought to assess the effects of continuous and discontinuous tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84fbb69db741987f2b7f88f471fd290b
https://pubmed.ncbi.nlm.nih.gov/24418941
https://pubmed.ncbi.nlm.nih.gov/24418941
Autor:
Julien Camous, Virginie Louvain-Quintard, François Stéphan, Philippe Dartevelle, Thibaut Decrombecque, Sylvie Doubine
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 46(1)
OBJECTIVES: Antiphospholipid syndrome (APS) is a risk factor for chronic thromboembolic pulmonary hypertension, for which the treatment of choice is pulmonary endarterectomy. The increased risk of postoperative thrombotic complications in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e0836a94260bdd7e6a8e9bad8ff519
https://pubmed.ncbi.nlm.nih.gov/24362260
https://pubmed.ncbi.nlm.nih.gov/24362260